Vivoryon Therapeutics AG (GB:0R3M) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vivoryon Therapeutics N.V., a clinical stage biotechnology company, successfully held its Annual General Meeting, with shareholders approving all agenda items. The company, which specializes in small molecule medicines for diseases like Alzheimer’s and cancer, has made all AGM-related documents available on its website.
For further insights into GB:0R3M stock, check out TipRanks’ Stock Analysis page.